

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.11478562 |
| 2 | presynaptic membrane assembly (GO:0097105) | 5.06787242 |
| 3 | neuron cell-cell adhesion (GO:0007158) | 4.85719485 |
| 4 | presynaptic membrane organization (GO:0097090) | 4.67134824 |
| 5 | behavioral response to nicotine (GO:0035095) | 4.59504568 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 4.56434219 |
| 7 | neuronal action potential propagation (GO:0019227) | 4.51176882 |
| 8 | vocalization behavior (GO:0071625) | 4.49887950 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.40136356 |
| 10 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.39342713 |
| 11 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.37917553 |
| 12 | postsynaptic membrane organization (GO:0001941) | 4.37247025 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.32663855 |
| 14 | protein localization to synapse (GO:0035418) | 4.22895674 |
| 15 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.18495159 |
| 16 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.15984786 |
| 17 | nucleobase catabolic process (GO:0046113) | 4.14173202 |
| 18 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.11557894 |
| 19 | synaptic vesicle maturation (GO:0016188) | 4.00292188 |
| 20 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.94568622 |
| 21 | glutamate secretion (GO:0014047) | 3.89558903 |
| 22 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.80590123 |
| 23 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.78852346 |
| 24 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.73704501 |
| 25 | regulation of synaptic vesicle transport (GO:1902803) | 3.72798948 |
| 26 | neuron-neuron synaptic transmission (GO:0007270) | 3.71043442 |
| 27 | synaptic transmission, glutamatergic (GO:0035249) | 3.68813683 |
| 28 | locomotory exploration behavior (GO:0035641) | 3.65751663 |
| 29 | glutamate receptor signaling pathway (GO:0007215) | 3.54895241 |
| 30 | startle response (GO:0001964) | 3.52568105 |
| 31 | gamma-aminobutyric acid transport (GO:0015812) | 3.51868663 |
| 32 | neurotransmitter secretion (GO:0007269) | 3.47771782 |
| 33 | nonmotile primary cilium assembly (GO:0035058) | 3.47457676 |
| 34 | negative regulation of neurotransmitter transport (GO:0051589) | 3.45389224 |
| 35 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.40270951 |
| 36 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.38517065 |
| 37 | protein polyglutamylation (GO:0018095) | 3.31414732 |
| 38 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.29587599 |
| 39 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.29542141 |
| 40 | central nervous system myelination (GO:0022010) | 3.29162269 |
| 41 | axon ensheathment in central nervous system (GO:0032291) | 3.29162269 |
| 42 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.28504370 |
| 43 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.28255179 |
| 44 | transmission of nerve impulse (GO:0019226) | 3.27942011 |
| 45 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.25030215 |
| 46 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.22979002 |
| 47 | cerebellar granule cell differentiation (GO:0021707) | 3.22697477 |
| 48 | retinal ganglion cell axon guidance (GO:0031290) | 3.22659542 |
| 49 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.21897991 |
| 50 | long-term synaptic potentiation (GO:0060291) | 3.21659743 |
| 51 | positive regulation of membrane potential (GO:0045838) | 3.19288170 |
| 52 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.16862214 |
| 53 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.13523163 |
| 54 | neuron recognition (GO:0008038) | 3.13389204 |
| 55 | regulation of neurotransmitter secretion (GO:0046928) | 3.11469225 |
| 56 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.10529549 |
| 57 | C4-dicarboxylate transport (GO:0015740) | 3.09181484 |
| 58 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.08332666 |
| 59 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.07149701 |
| 60 | exploration behavior (GO:0035640) | 3.06363074 |
| 61 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.06069200 |
| 62 | positive regulation of synapse assembly (GO:0051965) | 3.05756057 |
| 63 | regulation of postsynaptic membrane potential (GO:0060078) | 3.05129204 |
| 64 | establishment of mitochondrion localization (GO:0051654) | 3.04040117 |
| 65 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.03218473 |
| 66 | regulation of synapse structural plasticity (GO:0051823) | 3.02565136 |
| 67 | adult walking behavior (GO:0007628) | 3.01797289 |
| 68 | neurotransmitter transport (GO:0006836) | 3.01278082 |
| 69 | response to pheromone (GO:0019236) | 2.97466373 |
| 70 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.95591951 |
| 71 | regulation of respiratory system process (GO:0044065) | 2.95117136 |
| 72 | regulation of neurotransmitter transport (GO:0051588) | 2.95105618 |
| 73 | mechanosensory behavior (GO:0007638) | 2.95080717 |
| 74 | long-term memory (GO:0007616) | 2.94122922 |
| 75 | synapse assembly (GO:0007416) | 2.91586248 |
| 76 | neuromuscular synaptic transmission (GO:0007274) | 2.91463825 |
| 77 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.90558348 |
| 78 | striatum development (GO:0021756) | 2.88051196 |
| 79 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.87662939 |
| 80 | neurotransmitter uptake (GO:0001504) | 2.86679136 |
| 81 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.85669403 |
| 82 | dendrite development (GO:0016358) | 2.84676621 |
| 83 | membrane hyperpolarization (GO:0060081) | 2.84000193 |
| 84 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.82757516 |
| 85 | L-amino acid import (GO:0043092) | 2.82593975 |
| 86 | membrane depolarization during action potential (GO:0086010) | 2.80170949 |
| 87 | limb bud formation (GO:0060174) | 2.78243202 |
| 88 | learning (GO:0007612) | 2.78111021 |
| 89 | positive regulation of neurotransmitter transport (GO:0051590) | 2.77990307 |
| 90 | membrane depolarization (GO:0051899) | 2.77821604 |
| 91 | regulation of synaptic plasticity (GO:0048167) | 2.77558021 |
| 92 | neuromuscular process controlling posture (GO:0050884) | 2.76890733 |
| 93 | auditory behavior (GO:0031223) | 2.76850762 |
| 94 | negative regulation of dendrite development (GO:2000171) | 2.76653650 |
| 95 | regulation of cilium movement (GO:0003352) | 2.75382089 |
| 96 | neuronal ion channel clustering (GO:0045161) | 2.73984108 |
| 97 | transferrin transport (GO:0033572) | 2.73805839 |
| 98 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.71931045 |
| 99 | regulation of glutamate secretion (GO:0014048) | 2.69709757 |
| 100 | positive regulation of action potential (GO:0045760) | 2.69260037 |
| 101 | olfactory bulb development (GO:0021772) | 2.68608518 |
| 102 | dendritic spine morphogenesis (GO:0060997) | 2.68561170 |
| 103 | synaptic transmission (GO:0007268) | 2.67242497 |
| 104 | regulation of neurotransmitter levels (GO:0001505) | 2.67170445 |
| 105 | epithelial cilium movement (GO:0003351) | 2.66910504 |
| 106 | synaptic vesicle endocytosis (GO:0048488) | 2.66183898 |
| 107 | axonal fasciculation (GO:0007413) | 2.65813192 |
| 108 | membrane assembly (GO:0071709) | 2.65423132 |
| 109 | response to auditory stimulus (GO:0010996) | 2.65226089 |
| 110 | positive regulation of synaptic transmission (GO:0050806) | 2.64932205 |
| 111 | neuronal action potential (GO:0019228) | 2.64727972 |
| 112 | protein localization to cilium (GO:0061512) | 2.63517734 |
| 113 | regulation of female receptivity (GO:0045924) | 2.63507172 |
| 114 | response to histamine (GO:0034776) | 2.62729633 |
| 115 | behavioral response to cocaine (GO:0048148) | 2.62504747 |
| 116 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.62243049 |
| 117 | calcium ion-dependent exocytosis (GO:0017156) | 2.62149629 |
| 118 | amino acid import (GO:0043090) | 2.59891377 |
| 119 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.58589065 |
| 120 | cell migration in hindbrain (GO:0021535) | 2.57125965 |
| 121 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.56036498 |
| 122 | retinal cone cell development (GO:0046549) | 2.54726228 |
| 123 | spinal cord development (GO:0021510) | 2.54449530 |
| 124 | central nervous system neuron axonogenesis (GO:0021955) | 2.49897713 |
| 125 | behavioral response to ethanol (GO:0048149) | 2.48406631 |
| 126 | synaptic transmission, cholinergic (GO:0007271) | 2.48182740 |
| 127 | somite development (GO:0061053) | 2.46734674 |
| 128 | regulation of microtubule-based movement (GO:0060632) | 2.46526833 |
| 129 | neurofilament cytoskeleton organization (GO:0060052) | 2.45550722 |
| 130 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.44174952 |
| 131 | dendrite morphogenesis (GO:0048813) | 2.41275795 |
| 132 | glycosphingolipid biosynthetic process (GO:0006688) | 2.40966170 |
| 133 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.40889135 |
| 134 | head development (GO:0060322) | 2.40739735 |
| 135 | adult behavior (GO:0030534) | 2.39520001 |
| 136 | protein complex biogenesis (GO:0070271) | 2.39367251 |
| 137 | hippocampus development (GO:0021766) | 2.39067985 |
| 138 | synapse organization (GO:0050808) | 2.38354280 |
| 139 | intraciliary transport (GO:0042073) | 2.38300807 |
| 140 | cilium movement (GO:0003341) | 2.37679279 |
| 141 | inner ear receptor stereocilium organization (GO:0060122) | 2.37563936 |
| 142 | primary amino compound metabolic process (GO:1901160) | 2.36674621 |
| 143 | cilium morphogenesis (GO:0060271) | 2.36533978 |
| 144 | regulation of synapse assembly (GO:0051963) | 2.36262105 |
| 145 | serotonin metabolic process (GO:0042428) | 2.33555900 |
| 146 | behavioral fear response (GO:0001662) | 2.33455222 |
| 147 | behavioral defense response (GO:0002209) | 2.33455222 |
| 148 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.33174666 |
| 149 | neural tube formation (GO:0001841) | 2.33068273 |
| 150 | regulation of collateral sprouting (GO:0048670) | 2.32869132 |
| 151 | spinal cord motor neuron differentiation (GO:0021522) | 2.32819121 |
| 152 | cilium organization (GO:0044782) | 2.31951152 |
| 153 | NADH dehydrogenase complex assembly (GO:0010257) | 2.31665957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.97138178 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.27244061 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.85822839 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.72025597 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.70458444 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.52045395 |
| 7 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.42012718 |
| 8 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.31832008 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.30676016 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.30676016 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.30450991 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.29954921 |
| 13 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.27323951 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.26727259 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.25860352 |
| 16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.22508953 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.20519326 |
| 18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.19030737 |
| 19 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.10731647 |
| 20 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.10625999 |
| 21 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.10387533 |
| 22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.06854256 |
| 23 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.97519727 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.96910947 |
| 25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.92338697 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.89680553 |
| 27 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.85296084 |
| 28 | EWS_26573619_Chip-Seq_HEK293_Human | 1.84063501 |
| 29 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.83931639 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.83756668 |
| 31 | P300_19829295_ChIP-Seq_ESCs_Human | 1.81936607 |
| 32 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.80601645 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.80516805 |
| 34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.80505202 |
| 35 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.78049478 |
| 36 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.77383551 |
| 37 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.70796387 |
| 38 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.69837140 |
| 39 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.69184639 |
| 40 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.68676290 |
| 41 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.65760821 |
| 42 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.65640189 |
| 43 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.63907914 |
| 44 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.61877246 |
| 45 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.60228079 |
| 46 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.58962508 |
| 47 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.58591974 |
| 48 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.57105139 |
| 49 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.55869418 |
| 50 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.52342747 |
| 51 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.52218951 |
| 52 | FUS_26573619_Chip-Seq_HEK293_Human | 1.51618139 |
| 53 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.50280703 |
| 54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.48224100 |
| 55 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.48217926 |
| 56 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.47281382 |
| 57 | VDR_22108803_ChIP-Seq_LS180_Human | 1.46400188 |
| 58 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.46366646 |
| 59 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.45476744 |
| 60 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.44855670 |
| 61 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.44421738 |
| 62 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.38270916 |
| 63 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.38270916 |
| 64 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.36067366 |
| 65 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.35344370 |
| 66 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34865203 |
| 67 | STAT3_23295773_ChIP-Seq_U87_Human | 1.34637876 |
| 68 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.31238538 |
| 69 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.28071120 |
| 70 | TCF4_23295773_ChIP-Seq_U87_Human | 1.25575200 |
| 71 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22881541 |
| 72 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.21960063 |
| 73 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.21173006 |
| 74 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.21093810 |
| 75 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20468050 |
| 76 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18946172 |
| 77 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.17248148 |
| 78 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.17154765 |
| 79 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15384905 |
| 80 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.14940726 |
| 81 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.13691768 |
| 82 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.13595111 |
| 83 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.12862923 |
| 84 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.12489670 |
| 85 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.11812086 |
| 86 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.11804821 |
| 87 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.11237109 |
| 88 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.10820932 |
| 89 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.10777771 |
| 90 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.10166400 |
| 91 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09759873 |
| 92 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.09759873 |
| 93 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09732527 |
| 94 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.09577209 |
| 95 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.08658441 |
| 96 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08488746 |
| 97 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.08421289 |
| 98 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.08301820 |
| 99 | * FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.06660704 |
| 100 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.06515058 |
| 101 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.06154714 |
| 102 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05524488 |
| 103 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.05441855 |
| 104 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.05033349 |
| 105 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04770154 |
| 106 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.04167246 |
| 107 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.03201949 |
| 108 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02411131 |
| 109 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.02094554 |
| 110 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.01603318 |
| 111 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.01552770 |
| 112 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00698914 |
| 113 | JUN_21703547_ChIP-Seq_K562_Human | 0.99626127 |
| 114 | KDM2B_26808549_Chip-Seq_REH_Human | 0.99440826 |
| 115 | AR_19668381_ChIP-Seq_PC3_Human | 0.99415665 |
| 116 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.97947267 |
| 117 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.97355639 |
| 118 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.96348850 |
| 119 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.95871382 |
| 120 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.95104965 |
| 121 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.94935655 |
| 122 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94853536 |
| 123 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.94836572 |
| 124 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.93973487 |
| 125 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93850038 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.61377925 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.24021923 |
| 3 | MP0004270_analgesia | 3.49323319 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.32023311 |
| 5 | MP0009046_muscle_twitch | 3.27253359 |
| 6 | MP0009745_abnormal_behavioral_response | 2.99083357 |
| 7 | MP0002064_seizures | 2.93548678 |
| 8 | MP0002272_abnormal_nervous_system | 2.76740383 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.76040316 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.66686820 |
| 11 | MP0001486_abnormal_startle_reflex | 2.54036416 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.50810612 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.50139110 |
| 14 | MP0005646_abnormal_pituitary_gland | 2.49979505 |
| 15 | MP0002736_abnormal_nociception_after | 2.35641326 |
| 16 | MP0002735_abnormal_chemical_nociception | 2.29865648 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.22348400 |
| 18 | MP0002102_abnormal_ear_morphology | 2.13496918 |
| 19 | MP0002067_abnormal_sensory_capabilities | 2.07778445 |
| 20 | MP0008877_abnormal_DNA_methylation | 1.99997441 |
| 21 | MP0001188_hyperpigmentation | 1.99329782 |
| 22 | MP0000778_abnormal_nervous_system | 1.92259950 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 1.89294007 |
| 24 | MP0001984_abnormal_olfaction | 1.89128511 |
| 25 | MP0001529_abnormal_vocalization | 1.87389775 |
| 26 | MP0008569_lethality_at_weaning | 1.81336532 |
| 27 | MP0005551_abnormal_eye_electrophysiolog | 1.79733467 |
| 28 | MP0003787_abnormal_imprinting | 1.78631710 |
| 29 | MP0006276_abnormal_autonomic_nervous | 1.77965119 |
| 30 | MP0004142_abnormal_muscle_tone | 1.76720710 |
| 31 | MP0000569_abnormal_digit_pigmentation | 1.76130888 |
| 32 | MP0005171_absent_coat_pigmentation | 1.75608562 |
| 33 | MP0002653_abnormal_ependyma_morphology | 1.75224424 |
| 34 | MP0001970_abnormal_pain_threshold | 1.74871263 |
| 35 | MP0001440_abnormal_grooming_behavior | 1.72149048 |
| 36 | MP0001905_abnormal_dopamine_level | 1.70983116 |
| 37 | MP0002733_abnormal_thermal_nociception | 1.70420401 |
| 38 | MP0002184_abnormal_innervation | 1.67933434 |
| 39 | MP0004924_abnormal_behavior | 1.64602316 |
| 40 | MP0005386_behavior/neurological_phenoty | 1.64602316 |
| 41 | MP0004885_abnormal_endolymph | 1.64182622 |
| 42 | MP0002822_catalepsy | 1.62385403 |
| 43 | MP0003121_genomic_imprinting | 1.61877782 |
| 44 | MP0005645_abnormal_hypothalamus_physiol | 1.61250959 |
| 45 | MP0002557_abnormal_social/conspecific_i | 1.57556470 |
| 46 | MP0001986_abnormal_taste_sensitivity | 1.56542251 |
| 47 | MP0001501_abnormal_sleep_pattern | 1.55853038 |
| 48 | MP0003122_maternal_imprinting | 1.55127859 |
| 49 | MP0004133_heterotaxia | 1.53874697 |
| 50 | MP0000920_abnormal_myelination | 1.53397766 |
| 51 | MP0002882_abnormal_neuron_morphology | 1.49835939 |
| 52 | MP0005409_darkened_coat_color | 1.44055169 |
| 53 | MP0000955_abnormal_spinal_cord | 1.43006424 |
| 54 | MP0002938_white_spotting | 1.37155522 |
| 55 | MP0004742_abnormal_vestibular_system | 1.35522409 |
| 56 | MP0004811_abnormal_neuron_physiology | 1.33895590 |
| 57 | MP0002066_abnormal_motor_capabilities/c | 1.31458600 |
| 58 | MP0002229_neurodegeneration | 1.30729436 |
| 59 | MP0002234_abnormal_pharynx_morphology | 1.28788481 |
| 60 | MP0003879_abnormal_hair_cell | 1.28190309 |
| 61 | MP0002876_abnormal_thyroid_physiology | 1.24201421 |
| 62 | MP0000049_abnormal_middle_ear | 1.23874097 |
| 63 | MP0004145_abnormal_muscle_electrophysio | 1.22594276 |
| 64 | MP0004858_abnormal_nervous_system | 1.20207737 |
| 65 | MP0003011_delayed_dark_adaptation | 1.20197427 |
| 66 | MP0003634_abnormal_glial_cell | 1.19171373 |
| 67 | MP0000751_myopathy | 1.19068749 |
| 68 | MP0001502_abnormal_circadian_rhythm | 1.18976781 |
| 69 | MP0001963_abnormal_hearing_physiology | 1.17809514 |
| 70 | MP0000631_abnormal_neuroendocrine_gland | 1.15420744 |
| 71 | MP0002752_abnormal_somatic_nervous | 1.10254804 |
| 72 | MP0002837_dystrophic_cardiac_calcinosis | 1.09402742 |
| 73 | MP0001293_anophthalmia | 1.09307326 |
| 74 | MP0003633_abnormal_nervous_system | 1.09175658 |
| 75 | MP0003890_abnormal_embryonic-extraembry | 1.08847469 |
| 76 | MP0001485_abnormal_pinna_reflex | 1.06949935 |
| 77 | MP0003631_nervous_system_phenotype | 1.04843278 |
| 78 | MP0003136_yellow_coat_color | 1.03736174 |
| 79 | MP0005253_abnormal_eye_physiology | 1.03551011 |
| 80 | MP0003329_amyloid_beta_deposits | 1.01201404 |
| 81 | MP0003690_abnormal_glial_cell | 1.00402043 |
| 82 | MP0002152_abnormal_brain_morphology | 0.99295598 |
| 83 | MP0000566_synostosis | 0.98856631 |
| 84 | MP0006292_abnormal_olfactory_placode | 0.98531859 |
| 85 | MP0005410_abnormal_fertilization | 0.97145517 |
| 86 | MP0005499_abnormal_olfactory_system | 0.96474019 |
| 87 | MP0005394_taste/olfaction_phenotype | 0.96474019 |
| 88 | MP0003861_abnormal_nervous_system | 0.95651087 |
| 89 | MP0003119_abnormal_digestive_system | 0.95165581 |
| 90 | MP0008872_abnormal_physiological_respon | 0.91308116 |
| 91 | MP0003632_abnormal_nervous_system | 0.90885994 |
| 92 | MP0006072_abnormal_retinal_apoptosis | 0.90091645 |
| 93 | MP0000026_abnormal_inner_ear | 0.89654302 |
| 94 | MP0003937_abnormal_limbs/digits/tail_de | 0.88694292 |
| 95 | MP0001177_atelectasis | 0.87169940 |
| 96 | MP0004085_abnormal_heartbeat | 0.86914139 |
| 97 | MP0005391_vision/eye_phenotype | 0.86351184 |
| 98 | MP0005187_abnormal_penis_morphology | 0.85505033 |
| 99 | MP0002233_abnormal_nose_morphology | 0.85301884 |
| 100 | MP0005084_abnormal_gallbladder_morpholo | 0.84926347 |
| 101 | MP0002928_abnormal_bile_duct | 0.84588549 |
| 102 | MP0003698_abnormal_male_reproductive | 0.81829207 |
| 103 | MP0003283_abnormal_digestive_organ | 0.78227233 |
| 104 | MP0010386_abnormal_urinary_bladder | 0.76380114 |
| 105 | MP0003646_muscle_fatigue | 0.76339710 |
| 106 | MP0004043_abnormal_pH_regulation | 0.76320214 |
| 107 | MP0000015_abnormal_ear_pigmentation | 0.74308034 |
| 108 | MP0005195_abnormal_posterior_eye | 0.73691234 |
| 109 | MP0002090_abnormal_vision | 0.73369846 |
| 110 | MP0004215_abnormal_myocardial_fiber | 0.72933416 |
| 111 | MP0002638_abnormal_pupillary_reflex | 0.71923062 |
| 112 | MP0002069_abnormal_eating/drinking_beha | 0.71522680 |
| 113 | MP0001299_abnormal_eye_distance/ | 0.71380861 |
| 114 | MP0002751_abnormal_autonomic_nervous | 0.71238037 |
| 115 | MP0002909_abnormal_adrenal_gland | 0.69494088 |
| 116 | MP0003938_abnormal_ear_development | 0.68608478 |
| 117 | MP0004134_abnormal_chest_morphology | 0.68363028 |
| 118 | MP0004147_increased_porphyrin_level | 0.66678865 |
| 119 | MP0003137_abnormal_impulse_conducting | 0.65753915 |
| 120 | MP0003183_abnormal_peptide_metabolism | 0.65396561 |
| 121 | MP0001943_abnormal_respiration | 0.65349827 |
| 122 | MP0000749_muscle_degeneration | 0.64576435 |
| 123 | MP0008789_abnormal_olfactory_epithelium | 0.64490336 |
| 124 | MP0005623_abnormal_meninges_morphology | 0.64358711 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.86834358 |
| 2 | Atonic seizures (HP:0010819) | 5.03878235 |
| 3 | Myokymia (HP:0002411) | 4.82137891 |
| 4 | Febrile seizures (HP:0002373) | 4.67255066 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.65850857 |
| 6 | Focal seizures (HP:0007359) | 4.27841500 |
| 7 | Hyperventilation (HP:0002883) | 3.75896771 |
| 8 | Pancreatic cysts (HP:0001737) | 3.42678215 |
| 9 | Pheochromocytoma (HP:0002666) | 3.41235645 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 3.41150307 |
| 11 | Absence seizures (HP:0002121) | 3.39079793 |
| 12 | Pancreatic fibrosis (HP:0100732) | 3.32282649 |
| 13 | Gait imbalance (HP:0002141) | 3.31545505 |
| 14 | Dialeptic seizures (HP:0011146) | 3.21540107 |
| 15 | Medial flaring of the eyebrow (HP:0010747) | 3.19184792 |
| 16 | Molar tooth sign on MRI (HP:0002419) | 3.17910579 |
| 17 | Abnormality of midbrain morphology (HP:0002418) | 3.17910579 |
| 18 | Nephronophthisis (HP:0000090) | 3.15355610 |
| 19 | Gaze-evoked nystagmus (HP:0000640) | 3.15058028 |
| 20 | Neuroendocrine neoplasm (HP:0100634) | 3.12030550 |
| 21 | Congenital primary aphakia (HP:0007707) | 3.06377676 |
| 22 | Broad-based gait (HP:0002136) | 3.03895254 |
| 23 | Nephrogenic diabetes insipidus (HP:0009806) | 2.93611292 |
| 24 | Action tremor (HP:0002345) | 2.87714245 |
| 25 | Generalized tonic-clonic seizures (HP:0002069) | 2.86294947 |
| 26 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.84941118 |
| 27 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.84941118 |
| 28 | Visual hallucinations (HP:0002367) | 2.82284434 |
| 29 | Ankle clonus (HP:0011448) | 2.77962438 |
| 30 | Abnormal hair whorl (HP:0010721) | 2.73880349 |
| 31 | Scanning speech (HP:0002168) | 2.69045251 |
| 32 | Truncal ataxia (HP:0002078) | 2.65762627 |
| 33 | Type II lissencephaly (HP:0007260) | 2.65552734 |
| 34 | Absent/shortened dynein arms (HP:0200106) | 2.63632588 |
| 35 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.63632588 |
| 36 | Progressive inability to walk (HP:0002505) | 2.62317418 |
| 37 | Abnormality of the renal medulla (HP:0100957) | 2.61621469 |
| 38 | Lissencephaly (HP:0001339) | 2.60464383 |
| 39 | Chronic hepatic failure (HP:0100626) | 2.59196471 |
| 40 | Abnormality of the corticospinal tract (HP:0002492) | 2.50513017 |
| 41 | Hypothermia (HP:0002045) | 2.49725806 |
| 42 | Optic nerve hypoplasia (HP:0000609) | 2.48870199 |
| 43 | Vaginal atresia (HP:0000148) | 2.48320183 |
| 44 | Genital tract atresia (HP:0001827) | 2.46911861 |
| 45 | Sensory axonal neuropathy (HP:0003390) | 2.44109154 |
| 46 | Limb dystonia (HP:0002451) | 2.41469280 |
| 47 | Intestinal atresia (HP:0011100) | 2.41138384 |
| 48 | Septo-optic dysplasia (HP:0100842) | 2.40693456 |
| 49 | Spastic gait (HP:0002064) | 2.39747053 |
| 50 | Dysdiadochokinesis (HP:0002075) | 2.38120351 |
| 51 | Fetal akinesia sequence (HP:0001989) | 2.37042179 |
| 52 | Specific learning disability (HP:0001328) | 2.35050527 |
| 53 | Dysmetria (HP:0001310) | 2.33447783 |
| 54 | Anxiety (HP:0000739) | 2.31888140 |
| 55 | Supranuclear gaze palsy (HP:0000605) | 2.30702370 |
| 56 | Retinal dysplasia (HP:0007973) | 2.29174887 |
| 57 | Narrow nasal bridge (HP:0000446) | 2.23681207 |
| 58 | Poor coordination (HP:0002370) | 2.23632828 |
| 59 | Pachygyria (HP:0001302) | 2.22515028 |
| 60 | Abnormal eating behavior (HP:0100738) | 2.21570550 |
| 61 | Cystic liver disease (HP:0006706) | 2.21284603 |
| 62 | Thickened helices (HP:0000391) | 2.21124503 |
| 63 | Acute necrotizing encephalopathy (HP:0006965) | 2.19508613 |
| 64 | Blue irides (HP:0000635) | 2.19445681 |
| 65 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.18850443 |
| 66 | Pendular nystagmus (HP:0012043) | 2.18567178 |
| 67 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.18066319 |
| 68 | Absent speech (HP:0001344) | 2.17295483 |
| 69 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.17253623 |
| 70 | Lower limb muscle weakness (HP:0007340) | 2.13888406 |
| 71 | Depression (HP:0000716) | 2.12151061 |
| 72 | Progressive macrocephaly (HP:0004481) | 2.10400902 |
| 73 | Sclerocornea (HP:0000647) | 2.08588597 |
| 74 | Megalencephaly (HP:0001355) | 2.07326423 |
| 75 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.06199193 |
| 76 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.05715421 |
| 77 | Epileptiform EEG discharges (HP:0011182) | 2.05519992 |
| 78 | Failure to thrive in infancy (HP:0001531) | 2.05067620 |
| 79 | Excessive salivation (HP:0003781) | 2.03080361 |
| 80 | Drooling (HP:0002307) | 2.03080361 |
| 81 | Anencephaly (HP:0002323) | 2.02191057 |
| 82 | Akinesia (HP:0002304) | 2.00367219 |
| 83 | Acute encephalopathy (HP:0006846) | 2.00192782 |
| 84 | Postaxial hand polydactyly (HP:0001162) | 1.99600544 |
| 85 | Inability to walk (HP:0002540) | 1.98924573 |
| 86 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.96432460 |
| 87 | Aplasia involving bones of the extremities (HP:0009825) | 1.96139403 |
| 88 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.96139403 |
| 89 | Aplasia of the phalanges of the hand (HP:0009802) | 1.96139403 |
| 90 | Oligodactyly (hands) (HP:0001180) | 1.95356160 |
| 91 | Diplopia (HP:0000651) | 1.94072265 |
| 92 | Abnormality of binocular vision (HP:0011514) | 1.94072265 |
| 93 | Methylmalonic acidemia (HP:0002912) | 1.93791130 |
| 94 | Optic disc pallor (HP:0000543) | 1.93611026 |
| 95 | Hemiparesis (HP:0001269) | 1.93436662 |
| 96 | Amblyopia (HP:0000646) | 1.93019042 |
| 97 | Attenuation of retinal blood vessels (HP:0007843) | 1.92904120 |
| 98 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.91265452 |
| 99 | Abnormality of the renal cortex (HP:0011035) | 1.90852136 |
| 100 | Dyschromatopsia (HP:0007641) | 1.89849840 |
| 101 | Central scotoma (HP:0000603) | 1.89828303 |
| 102 | Hyperglycinemia (HP:0002154) | 1.88973271 |
| 103 | Termporal pattern (HP:0011008) | 1.88569016 |
| 104 | Insidious onset (HP:0003587) | 1.88569016 |
| 105 | Congenital stationary night blindness (HP:0007642) | 1.87962277 |
| 106 | EEG with generalized epileptiform discharges (HP:0011198) | 1.87554669 |
| 107 | Colon cancer (HP:0003003) | 1.84571731 |
| 108 | Poor eye contact (HP:0000817) | 1.82291338 |
| 109 | Abnormal ciliary motility (HP:0012262) | 1.82145075 |
| 110 | Polyphagia (HP:0002591) | 1.81729630 |
| 111 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.81601186 |
| 112 | Torticollis (HP:0000473) | 1.81182552 |
| 113 | Narrow forehead (HP:0000341) | 1.81115070 |
| 114 | Occipital encephalocele (HP:0002085) | 1.81045431 |
| 115 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.80927656 |
| 116 | Anophthalmia (HP:0000528) | 1.80720509 |
| 117 | Generalized myoclonic seizures (HP:0002123) | 1.80475517 |
| 118 | Protruding tongue (HP:0010808) | 1.79976926 |
| 119 | Poor suck (HP:0002033) | 1.79843880 |
| 120 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.78610334 |
| 121 | Postaxial foot polydactyly (HP:0001830) | 1.78456127 |
| 122 | Esotropia (HP:0000565) | 1.77756351 |
| 123 | Hypsarrhythmia (HP:0002521) | 1.77655494 |
| 124 | Supernumerary spleens (HP:0009799) | 1.77326984 |
| 125 | Spastic tetraplegia (HP:0002510) | 1.77053996 |
| 126 | Gastrointestinal atresia (HP:0002589) | 1.76669151 |
| 127 | Growth hormone deficiency (HP:0000824) | 1.76466239 |
| 128 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.75658631 |
| 129 | Hypoplasia of the brainstem (HP:0002365) | 1.75658631 |
| 130 | True hermaphroditism (HP:0010459) | 1.73397606 |
| 131 | Cerebellar dysplasia (HP:0007033) | 1.72572092 |
| 132 | Urinary urgency (HP:0000012) | 1.69955607 |
| 133 | Alacrima (HP:0000522) | 1.69948967 |
| 134 | Decreased central vision (HP:0007663) | 1.69918540 |
| 135 | Postural instability (HP:0002172) | 1.69700145 |
| 136 | Mitochondrial inheritance (HP:0001427) | 1.68931177 |
| 137 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.68197884 |
| 138 | Abolished electroretinogram (ERG) (HP:0000550) | 1.67786231 |
| 139 | Abnormality of the labia minora (HP:0012880) | 1.67686614 |
| 140 | Increased CSF lactate (HP:0002490) | 1.67060690 |
| 141 | Genetic anticipation (HP:0003743) | 1.66553784 |
| 142 | Increased corneal curvature (HP:0100692) | 1.66413487 |
| 143 | Keratoconus (HP:0000563) | 1.66413487 |
| 144 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.64939203 |
| 145 | Short tibia (HP:0005736) | 1.64826383 |
| 146 | Broad foot (HP:0001769) | 1.64280257 |
| 147 | Tubular atrophy (HP:0000092) | 1.63912168 |
| 148 | Chorioretinal atrophy (HP:0000533) | 1.63594881 |
| 149 | Congenital hepatic fibrosis (HP:0002612) | 1.61752513 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.35018740 |
| 2 | PRPF4B | 3.56425020 |
| 3 | MAP2K7 | 3.20641742 |
| 4 | NTRK3 | 3.16342350 |
| 5 | MAP3K4 | 2.54251853 |
| 6 | TNIK | 2.53211864 |
| 7 | MAP4K2 | 2.45282226 |
| 8 | EPHA4 | 2.33987017 |
| 9 | MARK1 | 2.33148982 |
| 10 | FRK | 2.29251823 |
| 11 | MAP3K12 | 2.26121114 |
| 12 | OXSR1 | 2.21794194 |
| 13 | CDK19 | 2.20974569 |
| 14 | AKT3 | 2.15094800 |
| 15 | MAPK13 | 1.97133646 |
| 16 | SGK223 | 1.89829509 |
| 17 | SGK494 | 1.89829509 |
| 18 | STK39 | 1.79841508 |
| 19 | SGK2 | 1.76107365 |
| 20 | MINK1 | 1.75990730 |
| 21 | PLK2 | 1.67570211 |
| 22 | TRIM28 | 1.59094542 |
| 23 | ZAK | 1.56953110 |
| 24 | NTRK2 | 1.56936143 |
| 25 | MUSK | 1.53366483 |
| 26 | NUAK1 | 1.38656167 |
| 27 | DAPK2 | 1.38430326 |
| 28 | NEK6 | 1.34703966 |
| 29 | MAP2K4 | 1.29899773 |
| 30 | BCR | 1.26907068 |
| 31 | CDK5 | 1.18570419 |
| 32 | UHMK1 | 1.18341322 |
| 33 | CAMKK2 | 1.18069095 |
| 34 | PRKCG | 1.18015338 |
| 35 | BMPR2 | 1.17601797 |
| 36 | MAP3K9 | 1.13657968 |
| 37 | PAK6 | 1.10101115 |
| 38 | SGK3 | 1.09955496 |
| 39 | GRK5 | 1.07463543 |
| 40 | PKN1 | 1.06574155 |
| 41 | YES1 | 1.06490248 |
| 42 | CSNK1G1 | 1.06402782 |
| 43 | CAMK2A | 1.05909422 |
| 44 | CAMK2B | 1.05869405 |
| 45 | PLK4 | 1.02661158 |
| 46 | STK16 | 1.00685987 |
| 47 | NTRK1 | 0.99061533 |
| 48 | PHKG2 | 0.98613245 |
| 49 | PHKG1 | 0.98613245 |
| 50 | PRKCE | 0.97872372 |
| 51 | CSNK1A1L | 0.97740691 |
| 52 | WNK1 | 0.93834950 |
| 53 | DAPK1 | 0.91225971 |
| 54 | EPHB2 | 0.91068792 |
| 55 | DYRK3 | 0.90210077 |
| 56 | SRPK1 | 0.89189347 |
| 57 | SIK3 | 0.88554005 |
| 58 | VRK1 | 0.88013833 |
| 59 | PINK1 | 0.87816647 |
| 60 | SIK2 | 0.86807153 |
| 61 | PRKCH | 0.83927829 |
| 62 | CCNB1 | 0.83517129 |
| 63 | EPHA3 | 0.83331728 |
| 64 | MKNK1 | 0.83230968 |
| 65 | CAMK2D | 0.82682012 |
| 66 | PRKD3 | 0.82484858 |
| 67 | PLK3 | 0.82170354 |
| 68 | ARAF | 0.82059626 |
| 69 | TNK2 | 0.80033076 |
| 70 | STK38L | 0.79302647 |
| 71 | ROCK2 | 0.77043641 |
| 72 | ADRBK2 | 0.74451390 |
| 73 | FES | 0.73634524 |
| 74 | TIE1 | 0.72441828 |
| 75 | WNK4 | 0.70444619 |
| 76 | PDK3 | 0.70186972 |
| 77 | PDK4 | 0.70186972 |
| 78 | TAF1 | 0.68959858 |
| 79 | CDK18 | 0.68333294 |
| 80 | ERBB3 | 0.67834920 |
| 81 | CAMKK1 | 0.67724159 |
| 82 | BCKDK | 0.67021279 |
| 83 | BRAF | 0.65982056 |
| 84 | CSNK1G2 | 0.65404053 |
| 85 | CDK14 | 0.65097677 |
| 86 | CAMK2G | 0.63722120 |
| 87 | MAPK15 | 0.63374693 |
| 88 | CDK15 | 0.61822011 |
| 89 | BMPR1B | 0.61116277 |
| 90 | SGK1 | 0.60948808 |
| 91 | GRK7 | 0.60609815 |
| 92 | DYRK2 | 0.59973640 |
| 93 | DYRK1A | 0.59157159 |
| 94 | MYLK | 0.58574786 |
| 95 | MAPKAPK5 | 0.56953863 |
| 96 | CAMK1 | 0.56019051 |
| 97 | MKNK2 | 0.55533401 |
| 98 | PDK2 | 0.55033308 |
| 99 | INSRR | 0.54476208 |
| 100 | KSR1 | 0.54387048 |
| 101 | LIMK1 | 0.54277586 |
| 102 | PNCK | 0.52747914 |
| 103 | PTK2B | 0.51603037 |
| 104 | PRKCZ | 0.50876853 |
| 105 | PAK3 | 0.50132077 |
| 106 | OBSCN | 0.50035443 |
| 107 | CDK11A | 0.49573327 |
| 108 | CSNK1A1 | 0.48801734 |
| 109 | ADRBK1 | 0.46822760 |
| 110 | CSNK1G3 | 0.46763528 |
| 111 | GRK1 | 0.45856110 |
| 112 | VRK2 | 0.45786806 |
| 113 | ROCK1 | 0.45566424 |
| 114 | FGFR2 | 0.45343311 |
| 115 | NME1 | 0.44398140 |
| 116 | CAMK1G | 0.44054997 |
| 117 | CDK3 | 0.43730482 |
| 118 | PIK3CA | 0.43628585 |
| 119 | PRKG1 | 0.42599038 |
| 120 | WNK3 | 0.42373154 |
| 121 | PRKACA | 0.42184045 |
| 122 | TSSK6 | 0.42045701 |
| 123 | ERBB4 | 0.41586707 |
| 124 | CSNK1E | 0.41374375 |
| 125 | DYRK1B | 0.40724664 |
| 126 | IRAK2 | 0.40178186 |
| 127 | TLK1 | 0.40035740 |
| 128 | STK11 | 0.40013056 |
| 129 | FGR | 0.39147810 |
| 130 | CSNK1D | 0.38200341 |
| 131 | RIPK4 | 0.37921570 |
| 132 | MAPK12 | 0.37866971 |
| 133 | CAMK4 | 0.36895310 |
| 134 | TYRO3 | 0.35653861 |
| 135 | PLK1 | 0.35502195 |
| 136 | RPS6KA5 | 0.35368296 |
| 137 | PRKACB | 0.35158201 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.65348797 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.51038912 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.72566155 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.67332077 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.65778888 |
| 6 | Phototransduction_Homo sapiens_hsa04744 | 2.62973288 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.56250097 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.55145793 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.46377829 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.38661988 |
| 11 | Protein export_Homo sapiens_hsa03060 | 2.18912963 |
| 12 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.13090774 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 2.01940012 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.00724847 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.96602063 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.95874633 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 1.89695396 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.82065521 |
| 19 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.75924977 |
| 20 | Salivary secretion_Homo sapiens_hsa04970 | 1.73904920 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.71432621 |
| 22 | Insulin secretion_Homo sapiens_hsa04911 | 1.69104777 |
| 23 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.65508244 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.65211644 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.62710090 |
| 26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.56241365 |
| 27 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.48280915 |
| 28 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.47209035 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.45599924 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.41040702 |
| 31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.40614454 |
| 32 | Renin secretion_Homo sapiens_hsa04924 | 1.40168764 |
| 33 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.40050211 |
| 34 | RNA polymerase_Homo sapiens_hsa03020 | 1.39021924 |
| 35 | Basal transcription factors_Homo sapiens_hsa03022 | 1.34901806 |
| 36 | Axon guidance_Homo sapiens_hsa04360 | 1.33533434 |
| 37 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.33330496 |
| 38 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.33003984 |
| 39 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.31137471 |
| 40 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.27199272 |
| 41 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.25532520 |
| 42 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.22031212 |
| 43 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.20393216 |
| 44 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.19160076 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.17203508 |
| 46 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.17109431 |
| 47 | Parkinsons disease_Homo sapiens_hsa05012 | 1.16548848 |
| 48 | Alzheimers disease_Homo sapiens_hsa05010 | 1.15689774 |
| 49 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.10277084 |
| 50 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.08646380 |
| 51 | Gap junction_Homo sapiens_hsa04540 | 1.07396349 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.06355823 |
| 53 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.04594231 |
| 54 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.02070141 |
| 55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.98967814 |
| 56 | RNA degradation_Homo sapiens_hsa03018 | 0.97870003 |
| 57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.96688566 |
| 58 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.95169147 |
| 59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.94666621 |
| 60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.94367255 |
| 61 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.93224383 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.93061585 |
| 63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.90954625 |
| 64 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.90703814 |
| 65 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.89640484 |
| 66 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.89597885 |
| 67 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.89177970 |
| 68 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.88656174 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86641457 |
| 70 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.81967508 |
| 71 | Melanogenesis_Homo sapiens_hsa04916 | 0.81307518 |
| 72 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.77381940 |
| 73 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.76814352 |
| 74 | Homologous recombination_Homo sapiens_hsa03440 | 0.75852361 |
| 75 | Huntingtons disease_Homo sapiens_hsa05016 | 0.74577078 |
| 76 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.74356083 |
| 77 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.74354159 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.73992817 |
| 79 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.72755386 |
| 80 | Phagosome_Homo sapiens_hsa04145 | 0.71335017 |
| 81 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.70910456 |
| 82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.70842754 |
| 83 | Peroxisome_Homo sapiens_hsa04146 | 0.69648597 |
| 84 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.67072208 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.67011934 |
| 86 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.64975503 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64734437 |
| 88 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.64038237 |
| 89 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.61337879 |
| 90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60927637 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59365781 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58798939 |
| 93 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58380831 |
| 94 | Glioma_Homo sapiens_hsa05214 | 0.57670126 |
| 95 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.54028147 |
| 96 | Purine metabolism_Homo sapiens_hsa00230 | 0.53648663 |
| 97 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.53613724 |
| 98 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.52946805 |
| 99 | Alcoholism_Homo sapiens_hsa05034 | 0.52210945 |
| 100 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51522368 |
| 101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.49464237 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48837435 |
| 103 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.48262034 |
| 104 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48237024 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47800077 |
| 106 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.46885345 |
| 107 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.46647920 |
| 108 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.46543869 |
| 109 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45953434 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45752136 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45699403 |
| 112 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.45246451 |
| 113 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.44913004 |
| 114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44083430 |
| 115 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.43233710 |
| 116 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.42402962 |
| 117 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41771906 |
| 118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41695737 |
| 119 | Endocytosis_Homo sapiens_hsa04144 | 0.41027072 |
| 120 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.40628857 |
| 121 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40363794 |
| 122 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.39702044 |
| 123 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.39647424 |
| 124 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39576595 |
| 125 | Proteasome_Homo sapiens_hsa03050 | 0.39298358 |
| 126 | Melanoma_Homo sapiens_hsa05218 | 0.39067039 |
| 127 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.38344043 |
| 128 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.37887736 |
| 129 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36643705 |
| 130 | RNA transport_Homo sapiens_hsa03013 | 0.35869228 |
| 131 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.35320745 |
| 132 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.34899942 |
| 133 | Ribosome_Homo sapiens_hsa03010 | 0.31827013 |
| 134 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.31541812 |
| 135 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.31062749 |
| 136 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.28620461 |
| 137 | Endometrial cancer_Homo sapiens_hsa05213 | 0.27779257 |
| 138 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.26149362 |
| 139 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.25132992 |

